Bloomberg Intelligence

GE's Danaher Deal Doesn't Solve Its Problem With Growth

Share this episode
Anyone with this link can open it.
Share Link
Start at 0:00

This episode isn’t summarized yet

Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.

Show notes

Brooke Sutherland, Bloomberg Opinion industrials columnist, on GE selling its BioPharma business to Danaher for $21.4 billion. Leland Miller, CEO of China Beige Book International, on the progress in US-China trade talks and deleveraging in China. John Kilduff, Founding Partner at Again Capital, on how Trump's tweet criticizing high oil prices may indicate a softening towards clamping down on Iranian sanctions waivers. Katherine Chiglinsky, U.S. finance reporter, on Berkshire Hathaway's annual letter and earnings results. Hosted by Abramowicz and Paul Sweeney. 

See omnystudio.com/listener for privacy information.

Couldn't load the audio. A blocker may be stopping the show's tracking links. Open the file